ctc | Cornell Micro/Nanofluidics Laboratory

Submitted, 2016: Automated electrorotation shows the electrokinetic separation in pancreatic cancer cells is robust to acquired chemotherapy resistance, serum starvation, and epithelial-to-mesenchymal transition

Accepted, Cytometry A, 2016: Comparison and Optimization of Machine Learning Methods for Automated Classification of Circulating Tumor Cells

22 Sep 2016: SciX: Genetic and functional analysis of single circulating tumor cells

9 Aug 2016: Gordon Conference on Rare Cells in Circulation: Manipulating rare cells and vesicles in microfluidic devices: Interrogating drug resistance and surgical risk staging

9 Nov 2015: AIChe-AES: Measuring Electrical Properties of Cancer Cells via Electrorotation

31 May 2015: Gordon Research Conference on Microfluidics: Controlling Microfluidic Transport for Rare Cell and Vesicle Capture

Biomedical Microdevices, 2015: A Transfer Function Approach for Predicting Rare Cell Capture Microdevice Performance

16 Feb 2015: 5th Annual Circulating Tumor Cells and Cell-Free DNA conference: Circulating Tumor Cells: linking analysis to surgical and medical care

Biomicrofluidics, 2015: Enhancing sensitivity and specificity in rare cell capture microdevices with dielectrophoresis

16 Nov 2014: AES Electrophoresis Society Meeting: Electrokinetic Manipulation for Characterization and Capture of Circulating Tumor Cells

Analytical Chemistry, 2014: Single-Cell Copy Number Analysis of Prostate Cancer Cells Captured with Geometrically Enhanced Differential Immunocapture Microdevices

26 Oct 2014: MicroTAS 2014: Parallel capture of pancreatic cancer cells

26 Oct 2014: MicroTAS 2014: Parallel capture of pancreatic cancer cells

22 Oct 2014: Biomedical Engineering Society Annual Meeting: Using Rare Cell Capture to Understand Metastasis

22 Oct 2014: Biomedical Engineering Society Annual Meeting: Using Rare Cell Capture to Understand Metastasis

3 Aug 2014: Gordon Research Conference on Rare Cells in Circulation: Single-nucleus sequencing of prostate cancer cells captured with GEDI microdevices

3 Aug 2014: Gordon Research Conference on Rare Cells in Circulation: Parallel capture of pancreatic cancer cells

3 Aug 2014: Gordon Research Conference on Rare Cells in Circulation: Parallel capture of pancreatic cancer cells

3 Aug 2014: Gordon Research Conference on Rare Cells in Circulation: Informing high performance capture of circulating tumor cells using a hybrid dielectrophoresis and immunocapture microdevice

Biomicrofluidics, 2014: Characterization of microfluidic shear-dependent epithelial cell adhesion molecule immunocapture and enrichment of pancreatic cancer cells from blood cells with dielectrophoresis

5 July 2014: Gordon Research Conference on Genomic Instability: Single-nucleus sequencing of prostate cancer cells captured with GEDI microdevices

5 July 2014: Gordon Research Conference on Genomic Instability: Single-nucleus sequencing of prostate cancer cells captured with GEDI microdevices

23 June 2014: Gordon Research Conference on Bioanalytical Sensors: Electrorotation of Cancer Cells to Optimize Performance of Dielectrophoresis Capture Devices

21 June 2014: Gordon Research Seminar on Bioanalytical Sensors: Electrorotation of Cancer Cells to Optimize Performance of Dielectrophoresis Capture Devices

15 June 2014: 13th International Summer School on Biocomplexity, Biodesign, and Bioinnovation: Using Rare Cell Capture to Understand Metastasis

15 June 2014: 13th International Summer School on Biocomplexity, Biodesign, and Bioinnovation: Using Rare Cell Capture to Understand Metastasis

13 Mar 2014: Cornell Materials Science Colloquium: Rare Cell Capture and Analysis in GEDI Microdevices: New Clinical and Engineering Opportunities

13 Mar 2014: Cornell Materials Science Colloquium: Rare Cell Capture and Analysis in GEDI Microdevices: New Clinical and Engineering Opportunities

7 Mar 2014: Sibley Graduate Research Symposium: Electrorotation of Cancer Cells to Optimize Performance of Dielectrophoresis Capture Devices

7 Mar 2014: Sibley Graduate Research Symposium: Electrorotation of Cancer Cells to Optimize Performance of Dielectrophoresis Capture Devices

Gastroenterology, 2014: Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions

Lab on a Chip, 2014: Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis

18 Jan 2014: Society for Lab Automation and Screening: Circulating tumor cell (CTC) cancer biomarkers using geometrically enhanced differential immunocapture (GEDI) microdevices

17 Jan 2014: Edwards Lecture, Oregon State University: Geometrically Enhanced Differential Immunocapture: Using obstacle arrays in microfluidic devices to enhance efficient and pure rare cell capture from fluid suspensions

17 Jan 2014: Edwards Lecture, Oregon State University: Geometrically Enhanced Differential Immunocapture: Using obstacle arrays in microfluidic devices to enhance efficient and pure rare cell capture from fluid suspensions

7 Jan 2014: Biomedical Engineering Society – Cellular and Molecular Bioengineering Meeting: On-chip Tumor Microenvironment for Circulating Tumor Cell Isolation and Culture

7 Jan 2014: Biomedical Engineering Society – Cellular and Molecular Bioengineering Meeting: On-chip Tumor Microenvironment for Circulating Tumor Cell Isolation and Culture

27 Oct 2013: MicroTAS: Parallelized microfluidic immunocapture of circulating pancreas cells for the early detection of pancreatic carcinogenesis

27 Oct 2013: MicroTAS: Enrichment of prostate cancer cells from blood cells with a hybrid dielectrophoresis and immunocapture microfluidic system

27 Oct 2013: MicroTAS: Enrichment of prostate cancer cells from blood cells with a hybrid dielectrophoresis and immunocapture microfluidic system

25 Sep 2013: BMES: A Hybrid Dielectrophoresis and Immunocapture System for Enhanced Capture of Circulating Tumor Cells

25 Sep 2013: BMES: A Hybrid Dielectrophoresis and Immunocapture System for Enhanced Capture of Circulating Tumor Cells

25 Sep 2013: BMES: Machine Learning Outperforms Manual Counting for Classifying Circulating Tumor Cells from Cancer Patients

25 Sep 2013: BMES: Machine Learning Outperforms Manual Counting for Classifying Circulating Tumor Cells from Cancer Patients

25 Sep 2013: BMES: Multiplexed Microfluidic Immunocapture of Circulating Pancreas Cells for the Early Detection of Pancreatic Carcinogenesis

19 Sep 2013: Cornell NanoScale Science & Technology Facility Annual Meeting: A Hybrid Dielectrophoresis and Immunocapture Microfluidic System for Enhanced Rare Cell Capture

19 Sep 2013: Cornell NanoScale Science & Technology Facility Annual Meeting: A Hybrid Dielectrophoresis and Immunocapture Microfluidic System for Enhanced Rare Cell Capture

Biomedical Microdevices, 2013: Enrichment of prostate cancer cells from blood cells with a hybrid dielectrophoresis and Immunocapture microfluidic system

9 Jun 2013: Gordon Research Conference on Microfluidics: Machine Learning Outperforms Manual Counting for Classifying Circulating Tumor Cells from Cancer Patients

9 Jun 2013: Gordon Research Conference on Microfluidics: Machine Learning Outperforms Manual Counting for Classifying Circulating Tumor Cells from Cancer Patients

9 Jun 2013: Gordon Research Conference on Microfluidics: Multiplexed Microfluidic Immunocapture of Circulating Pancreas Cells for the Early Detection of Pancreatic Carcinogenesis

9 Jun 2013: Gordon Research Conference on Microfluidics: Multiplexed Microfluidic Immunocapture of Circulating Pancreas Cells for the Early Detection of Pancreatic Carcinogenesis

9 Jun 2013: Gordon Research Conference on Microfluidics: Capture and interrogation of circulating tumors cells by use of geometrically enhanced differential immunocapture (GEDI) microfluidic devices

6 Jun 2013: Select Biosciences 2013 Nano and Microfluidics conference: Functional and Genetic Analysis of CTCs captured with GEDI Microdevices

31 May 2013: ASCO: TAXYNERGY (NCT01718353): A randomized phase II trial examining an early switch from first-line docetaxel to cabazitaxel, or cabazitaxel to docetaxel, in men with metastatic castration-resistant prostate cancer (mCRPC)

31 May 2013: ASCO: TAXYNERGY (NCT01718353): A randomized phase II trial examining an early switch from first-line docetaxel to cabazitaxel, or cabazitaxel to docetaxel, in men with metastatic castration-resistant prostate cancer (mCRPC)

6 Apr 2013: AACR: Development of a HER2-based GEDI microfluidic device for the molecular characterization of CTCs from metastatic breast cancer patients

6 Apr 2013: AACR: Development of a HER2-based GEDI microfluidic device for the molecular characterization of CTCs from metastatic breast cancer patients

6 Apr 2013: AACR: Using CTCs to interrogate mechanisms of taxane resistance in the prospective TAXYNERGY clinical trial in prostate cancer

6 Apr 2013: AACR: Using CTCs to interrogate mechanisms of taxane resistance in the prospective TAXYNERGY clinical trial in prostate cancer

17 Mar 2013: Pittcon: Functional Characterization of Circulating Tumor Cells Captured With GEDI Microdevices

17 Mar 2013: Pittcon: Functional Characterization of Circulating Tumor Cells Captured With GEDI Microdevices

10 Feb 2013: Gordon Research Conference on Fibronectin, Integrins, & Related Molecules: Capture and Interrogation of Circulating Tumor Cells in Tissue-Engineered Geometrically Enhanced Differential Immunocapture Microfluidic Devices

10 Feb 2013: Gordon Research Conference on Fibronectin, Integrins, & Related Molecules: Capture and Interrogation of Circulating Tumor Cells in Tissue-Engineered Geometrically Enhanced Differential Immunocapture Microfluidic Devices

Frontiers in Cancer Molecular Targets and Therapeutics, 2012: Isolation and characterization of circulating tumor cells in prostate cancer

Lab on a Chip, 2010: Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody

Lab on a Chip, 2010: Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody